Rheumatoid arthritis

Methotrexate risk for melanoma in doubt

Whether methotrexate is associated with an increased risk of melanoma remains uncertain with a Swedish study finding the use of the immunosuppressive drug in psoriasis patients does not increase their melanoma risk. However the findings contradict Australian evidence from 2008 that methotrexate use by patients with rheumatoid arthritis increases their risk of melanoma about three-fold. The ...

Already a member?

Login to keep reading.

© 2021 the limbic